Sea You at Fetch Long Beach
|Videos|September 8, 2021

Anivive Lifesciences strives to develop 'valley fever' prevention vaccine

Author(s)dvm360 Staff

Anivive Lifesciences' Chief Commerical Officer Chad Todd, DVM, discussed the future of Anivive Lifesciences including the development of a new vaccine.

In an interview from our Fetch dvm360® Kansas City Conference, Chad Todd, DVM, chief commercial officer at Anivive Lifesciences, shared insight on a new vaccine the company is working toward for the prevention of coccidioidomycosis, also referred to as “valley fever.”

"We are in the process of developing drugs not only in the oncology space, but we are also working on the development of a valley fever vaccine," Todd told dvm360® staff. "Valley fever is a condition that both people and pets are affected by and we do not have any preventions right now. It's very unfortunate because there are about 30 million dogs that are exposed to this pathogen."

He then explained that a person or canine diagnosed with this condition will likely endure lifelong therapy of antifungal treatments. Anivive strives to bring these unmet medical needs to the forefront by developing a preventative vaccine for valley fever.

Watch the full interview below for more information on Anvive Lifesciences and its mission.


Related to this article

Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Inside veterinary social work
In a slideshow drawn from an on-site dvm360 interview at the 2026 Fetch National Harbor Veterinary Conference, a veterinary oncologist and a veterinary social worker walk through how the role supports owners and staff across a pet's cancer diagnosis, treatment, and end-of-life care.